Lilly Endowment Inc holds a concentrated book of 1 reported position worth $84.5B as of Q1 2026 (disclosed Apr 20, 2026, a ~20-day 13F lag). This quarter they trimmed Eli Lilly & Co. Their largest long position is Eli Lilly & Co at 100% of the reported non-option book. Cloning the disclosed picks since 2013 would be +3050% (+30.6%/yr). That is a simulation of the disclosed long book, not audited returns.
Following at the filing date actually beat the quarter-end book by 708.3 points over this window.
Growth of $10,000 cloning Lilly Endowment Inc's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~20 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis
No buys this quarter.
Bars show each position's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company Common | $84.5B | 91.90M | 100.0% | ▼−0.3% Reduced · −294K sh |
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/316011/holdings"
Use Arkolith to show LILLY ENDOWMENT INC's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Reported 13F total per quarter. Raw filing totals can include option notional.
| Quarter | As of | Filed | Lag | Positions | Value | Form |
|---|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | Apr 20, 2026 | 20d | 1 | $84.5B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Jan 23, 2026 | 23d | 1 | $99.1B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 31, 2025 | 31d | 1 | $72.9B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 10, 2025 | 10d | 1 | $74.8B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 16, 2025 | 16d | 1 | $79.3B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 27, 2025 | 27d | 1 | $74.8B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Oct 3, 2024 | 3d | 1 | $85.8B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Jul 16, 2024 | 16d | 1 | $88.2B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | Apr 16, 2024 | 16d | 1 | $76.9B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Jan 25, 2024 | 25d | 1 | $58.2B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Oct 12, 2023 | 12d | 1 | $53.7B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Jul 10, 2023 | 10d | 1 | $47.4B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | Apr 17, 2023 | 17d | 1 | $35.2B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Jan 26, 2023 | 26d | 1 | $37.7B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Oct 5, 2022 | 5d | 1 | $33.6B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Jul 18, 2022 | 18d | 1 | $33.8B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | Apr 19, 2022 | 19d | 1 | $30.4B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Jan 27, 2022 | 27d | 1 | $29.7B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Oct 8, 2021 | 8d | 1 | $25.0B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Jul 19, 2021 | 19d | 1 | $25.1B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | Apr 12, 2021 | 12d | 1 | $20.6B | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Jan 21, 2021 | 21d | 1 | $18.8B | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Oct 5, 2020 | 5d | 1 | $16.4B | 13F-HR |
| Q2 2020 | Jun 30, 2020 | Jul 16, 2020 | 16d | 1 | $18.3B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. Book totals and portfolio weights cover reported non-option positions, which can include notes and warrants. Disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.